database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,12 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,24 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,36 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Cancer,Solid Cancer,421,481,12 months,7,1.4553014553
MPCD,DMARD,Cancer,Solid Cancer,421,481,24 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,36 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,12 months,3,0.6237006237
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,24 months,3,0.6237006237
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,36 months,4,0.8316008316
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Infection,Hospitalized infection,421,481,12 months,6,1.2474012474
MPCD,DMARD,Infection,Hospitalized infection,421,481,24 months,11,2.2869022869
MPCD,DMARD,Infection,Hospitalized infection,421,481,36 months,14,2.9106029106
MPCD,DMARD,Infection,Hospitalized infection,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Infection,Opportunistic infection,421,481,12 months,5,1.0395010395
MPCD,DMARD,Infection,Opportunistic infection,421,481,24 months,9,1.8711018711
MPCD,DMARD,Infection,Opportunistic infection,421,481,36 months,13,2.7027027027
MPCD,DMARD,Infection,Opportunistic infection,421,481,AS cohort entry to exposure,3,0.6237006237
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,12 months,19,3.9501039501
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,24 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,36 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,AS cohort entry to exposure,14,2.9106029106
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,12 months,11,2.2869022869
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,24 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,36 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,AS cohort entry to exposure,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,12 months,2,0.4158004158
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,24 months,3,0.6237006237
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,36 months,4,0.8316008316
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,12 months,2,0.4158004158
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,24 months,3,0.6237006237
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,36 months,4,0.8316008316
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,12 months,4,0.8316008316
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,24 months,8,1.6632016632
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,36 months,11,2.2869022869
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,AS cohort entry to exposure,5,1.0395010395
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,12 months,7,1.4553014553
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,24 months,11,2.2869022869
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,36 months,14,2.9106029106
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,12 months,26,5.4054054054
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,24 months,30,6.237006237
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,36 months,31,6.4449064449
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,AS cohort entry to exposure,21,4.3659043659
MPCD,DMARD,Uveitis,Uveitis,421,481,12 months,35,7.2765072765
MPCD,DMARD,Uveitis,Uveitis,421,481,24 months,40,8.316008316
MPCD,DMARD,Uveitis,Uveitis,421,481,36 months,42,8.7318087318
MPCD,DMARD,Uveitis,Uveitis,421,481,AS cohort entry to exposure,28,5.8212058212
MPCD,NSAID,Cancer,Hematologic Cancer,763,1000,12 months,1,0.1
MPCD,NSAID,Cancer,Hematologic Cancer,763,1000,24 months,1,0.1
MPCD,NSAID,Cancer,Hematologic Cancer,763,1000,36 months,1,0.1
MPCD,NSAID,Cancer,Hematologic Cancer,763,1000,AS cohort entry to exposure,1,0.1
MPCD,NSAID,Cancer,Solid Cancer,763,1000,12 months,28,2.8
MPCD,NSAID,Cancer,Solid Cancer,763,1000,24 months,35,3.5
MPCD,NSAID,Cancer,Solid Cancer,763,1000,36 months,36,3.6
MPCD,NSAID,Cancer,Solid Cancer,763,1000,AS cohort entry to exposure,28,2.8
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,763,1000,12 months,2,0.2
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,763,1000,24 months,5,0.5
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,763,1000,36 months,5,0.5
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,763,1000,AS cohort entry to exposure,3,0.3
MPCD,NSAID,Cardiac disease,Conduction Block,763,1000,12 months,7,0.7
MPCD,NSAID,Cardiac disease,Conduction Block,763,1000,24 months,8,0.8
MPCD,NSAID,Cardiac disease,Conduction Block,763,1000,36 months,9,0.9
MPCD,NSAID,Cardiac disease,Conduction Block,763,1000,AS cohort entry to exposure,2,0.2
MPCD,NSAID,Cardiac disease,Myocardial infarction,763,1000,12 months,1,0.1
MPCD,NSAID,Cardiac disease,Myocardial infarction,763,1000,24 months,3,0.3
MPCD,NSAID,Cardiac disease,Myocardial infarction,763,1000,36 months,3,0.3
MPCD,NSAID,Cardiac disease,Myocardial infarction,763,1000,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Hospitalized infection,763,1000,12 months,7,0.7
MPCD,NSAID,Infection,Hospitalized infection,763,1000,24 months,13,1.3
MPCD,NSAID,Infection,Hospitalized infection,763,1000,36 months,14,1.4
MPCD,NSAID,Infection,Hospitalized infection,763,1000,AS cohort entry to exposure,11,1.1
MPCD,NSAID,Infection,Opportunistic infection,763,1000,12 months,5,0.5
MPCD,NSAID,Infection,Opportunistic infection,763,1000,24 months,6,0.6
MPCD,NSAID,Infection,Opportunistic infection,763,1000,36 months,7,0.7
MPCD,NSAID,Infection,Opportunistic infection,763,1000,AS cohort entry to exposure,7,0.7
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,763,1000,12 months,20,2
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,763,1000,24 months,23,2.3
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,763,1000,36 months,24,2.4
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,763,1000,AS cohort entry to exposure,18,1.8
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,763,1000,12 months,11,1.1
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,763,1000,24 months,13,1.3
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,763,1000,36 months,13,1.3
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,763,1000,AS cohort entry to exposure,15,1.5
MPCD,NSAID,Kidney disease,IgA nephropathy,763,1000,12 months,1,0.1
MPCD,NSAID,Kidney disease,IgA nephropathy,763,1000,24 months,3,0.3
MPCD,NSAID,Kidney disease,IgA nephropathy,763,1000,36 months,3,0.3
MPCD,NSAID,Kidney disease,IgA nephropathy,763,1000,AS cohort entry to exposure,1,0.1
MPCD,NSAID,Lung disease,Restrictive lung disease ,763,1000,12 months,9,0.9
MPCD,NSAID,Lung disease,Restrictive lung disease ,763,1000,24 months,14,1.4
MPCD,NSAID,Lung disease,Restrictive lung disease ,763,1000,36 months,16,1.6
MPCD,NSAID,Lung disease,Restrictive lung disease ,763,1000,AS cohort entry to exposure,10,1
MPCD,NSAID,Neurological Disease,Spinal Cord compression,763,1000,12 months,3,0.3
MPCD,NSAID,Neurological Disease,Spinal Cord compression,763,1000,24 months,4,0.4
MPCD,NSAID,Neurological Disease,Spinal Cord compression,763,1000,36 months,4,0.4
MPCD,NSAID,Neurological Disease,Spinal Cord compression,763,1000,AS cohort entry to exposure,3,0.3
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,763,1000,12 months,8,0.8
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,763,1000,24 months,9,0.9
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,763,1000,36 months,9,0.9
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,763,1000,AS cohort entry to exposure,5,0.5
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,763,1000,12 months,26,2.6
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,763,1000,24 months,35,3.5
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,763,1000,36 months,40,4
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,763,1000,AS cohort entry to exposure,18,1.8
MPCD,NSAID,PsO/PsA,Psoriasis,763,1000,12 months,15,1.5
MPCD,NSAID,PsO/PsA,Psoriasis,763,1000,24 months,17,1.7
MPCD,NSAID,PsO/PsA,Psoriasis,763,1000,36 months,19,1.9
MPCD,NSAID,PsO/PsA,Psoriasis,763,1000,AS cohort entry to exposure,18,1.8
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,763,1000,12 months,16,1.6
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,763,1000,24 months,20,2
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,763,1000,36 months,22,2.2
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,763,1000,AS cohort entry to exposure,14,1.4
MPCD,NSAID,Uveitis,Uveitis,763,1000,12 months,65,6.5
MPCD,NSAID,Uveitis,Uveitis,763,1000,24 months,72,7.2
MPCD,NSAID,Uveitis,Uveitis,763,1000,36 months,73,7.3
MPCD,NSAID,Uveitis,Uveitis,763,1000,AS cohort entry to exposure,57,5.7
MPCD,No exposure,Cancer,Hematologic Cancer,1593,1593,12 months,12,0.7532956685
MPCD,No exposure,Cancer,Hematologic Cancer,1593,1593,24 months,17,1.0671688638
MPCD,No exposure,Cancer,Hematologic Cancer,1593,1593,36 months,18,1.1299435028
MPCD,No exposure,Cancer,Hematologic Cancer,1593,1593,AS cohort entry to exposure,1,0.062774639
MPCD,No exposure,Cancer,Solid Cancer,1593,1593,12 months,82,5.1475204018
MPCD,No exposure,Cancer,Solid Cancer,1593,1593,24 months,114,7.1563088512
MPCD,No exposure,Cancer,Solid Cancer,1593,1593,36 months,127,7.9723791588
MPCD,No exposure,Cancer,Solid Cancer,1593,1593,AS cohort entry to exposure,14,0.8788449466
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1593,1593,12 months,39,2.4482109228
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1593,1593,24 months,50,3.1387319523
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1593,1593,36 months,57,3.5781544256
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1593,1593,AS cohort entry to exposure,4,0.2510985562
MPCD,No exposure,Cardiac disease,Conduction Block,1593,1593,12 months,16,1.0043942247
MPCD,No exposure,Cardiac disease,Conduction Block,1593,1593,24 months,21,1.31826742
MPCD,No exposure,Cardiac disease,Conduction Block,1593,1593,36 months,25,1.5693659761
MPCD,No exposure,Cardiac disease,Conduction Block,1593,1593,AS cohort entry to exposure,4,0.2510985562
MPCD,No exposure,Cardiac disease,Myocardial infarction,1593,1593,12 months,12,0.7532956685
MPCD,No exposure,Cardiac disease,Myocardial infarction,1593,1593,24 months,21,1.31826742
MPCD,No exposure,Cardiac disease,Myocardial infarction,1593,1593,36 months,22,1.381042059
MPCD,No exposure,Cardiac disease,Myocardial infarction,1593,1593,AS cohort entry to exposure,1,0.062774639
MPCD,No exposure,Infection,Hospitalized infection,1593,1593,12 months,138,8.6629001883
MPCD,No exposure,Infection,Hospitalized infection,1593,1593,24 months,173,10.860012555
MPCD,No exposure,Infection,Hospitalized infection,1593,1593,36 months,183,11.487758945
MPCD,No exposure,Infection,Hospitalized infection,1593,1593,AS cohort entry to exposure,64,4.0175768989
MPCD,No exposure,Infection,Opportunistic infection,1593,1593,12 months,16,1.0043942247
MPCD,No exposure,Infection,Opportunistic infection,1593,1593,24 months,19,1.1927181419
MPCD,No exposure,Infection,Opportunistic infection,1593,1593,36 months,23,1.4438166981
MPCD,No exposure,Infection,Opportunistic infection,1593,1593,AS cohort entry to exposure,1,0.062774639
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1593,1593,12 months,68,4.2686754551
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1593,1593,24 months,77,4.8336472065
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1593,1593,36 months,83,5.2102950408
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1593,1593,AS cohort entry to exposure,19,1.1927181419
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1593,1593,12 months,37,2.3226616447
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1593,1593,24 months,43,2.699309479
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1593,1593,36 months,44,2.762084118
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1593,1593,AS cohort entry to exposure,9,0.5649717514
MPCD,No exposure,Kidney disease,Amyloidosis,1593,1593,12 months,1,0.062774639
MPCD,No exposure,Kidney disease,Amyloidosis,1593,1593,24 months,2,0.1255492781
MPCD,No exposure,Kidney disease,Amyloidosis,1593,1593,36 months,3,0.1883239171
MPCD,No exposure,Kidney disease,Amyloidosis,1593,1593,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,1593,1593,12 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,1593,1593,24 months,1,0.062774639
MPCD,No exposure,Kidney disease,IgA nephropathy,1593,1593,36 months,3,0.1883239171
MPCD,No exposure,Kidney disease,IgA nephropathy,1593,1593,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1593,1593,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1593,1593,24 months,1,0.062774639
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1593,1593,36 months,1,0.062774639
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1593,1593,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1593,1593,12 months,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1593,1593,24 months,1,0.062774639
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1593,1593,36 months,1,0.062774639
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1593,1593,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Interstitial lung disease,1593,1593,12 months,2,0.1255492781
MPCD,No exposure,Lung disease,Interstitial lung disease,1593,1593,24 months,4,0.2510985562
MPCD,No exposure,Lung disease,Interstitial lung disease,1593,1593,36 months,4,0.2510985562
MPCD,No exposure,Lung disease,Interstitial lung disease,1593,1593,AS cohort entry to exposure,1,0.062774639
MPCD,No exposure,Lung disease,Restrictive lung disease ,1593,1593,12 months,31,1.9460138104
MPCD,No exposure,Lung disease,Restrictive lung disease ,1593,1593,24 months,49,3.0759573132
MPCD,No exposure,Lung disease,Restrictive lung disease ,1593,1593,36 months,54,3.3898305085
MPCD,No exposure,Lung disease,Restrictive lung disease ,1593,1593,AS cohort entry to exposure,10,0.6277463905
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1593,1593,12 months,4,0.2510985562
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1593,1593,24 months,5,0.3138731952
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1593,1593,36 months,5,0.3138731952
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1593,1593,AS cohort entry to exposure,3,0.1883239171
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1593,1593,12 months,3,0.1883239171
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1593,1593,24 months,4,0.2510985562
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1593,1593,36 months,6,0.3766478343
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1593,1593,AS cohort entry to exposure,1,0.062774639
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1593,1593,12 months,61,3.8292529818
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1593,1593,24 months,65,4.080351538
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1593,1593,36 months,70,4.3942247332
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1593,1593,AS cohort entry to exposure,15,0.9416195857
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1593,1593,12 months,60,3.7664783427
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1593,1593,24 months,84,5.2730696798
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1593,1593,36 months,96,6.0263653484
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1593,1593,AS cohort entry to exposure,15,0.9416195857
MPCD,No exposure,PsO/PsA,Psoriasis,1593,1593,12 months,34,2.1343377276
MPCD,No exposure,PsO/PsA,Psoriasis,1593,1593,24 months,49,3.0759573132
MPCD,No exposure,PsO/PsA,Psoriasis,1593,1593,36 months,52,3.2642812304
MPCD,No exposure,PsO/PsA,Psoriasis,1593,1593,AS cohort entry to exposure,8,0.5021971124
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1593,1593,12 months,47,2.9504080352
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1593,1593,24 months,56,3.5153797866
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1593,1593,36 months,64,4.0175768989
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1593,1593,AS cohort entry to exposure,15,0.9416195857
MPCD,No exposure,Uveitis,Uveitis,1593,1593,12 months,97,6.0891399874
MPCD,No exposure,Uveitis,Uveitis,1593,1593,24 months,118,7.4074074074
MPCD,No exposure,Uveitis,Uveitis,1593,1593,36 months,129,8.0979284369
MPCD,No exposure,Uveitis,Uveitis,1593,1593,AS cohort entry to exposure,25,1.5693659761
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,24 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,36 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,AS cohort entry to exposure,4,0.3127443315
MPCD,TNF,Cancer,Solid Cancer,1107,1279,12 months,33,2.5801407349
MPCD,TNF,Cancer,Solid Cancer,1107,1279,24 months,41,3.205629398
MPCD,TNF,Cancer,Solid Cancer,1107,1279,36 months,44,3.4401876466
MPCD,TNF,Cancer,Solid Cancer,1107,1279,AS cohort entry to exposure,19,1.4855355747
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,12 months,22,1.7200938233
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,24 months,27,2.1110242377
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,36 months,28,2.1892103206
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,12 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,24 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,36 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,24 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,36 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,AS cohort entry to exposure,3,0.2345582486
MPCD,TNF,Infection,Hospitalized infection,1107,1279,12 months,13,1.0164190774
MPCD,TNF,Infection,Hospitalized infection,1107,1279,24 months,22,1.7200938233
MPCD,TNF,Infection,Hospitalized infection,1107,1279,36 months,24,1.8764659891
MPCD,TNF,Infection,Hospitalized infection,1107,1279,AS cohort entry to exposure,14,1.0946051603
MPCD,TNF,Infection,Opportunistic infection,1107,1279,12 months,17,1.3291634089
MPCD,TNF,Infection,Opportunistic infection,1107,1279,24 months,22,1.7200938233
MPCD,TNF,Infection,Opportunistic infection,1107,1279,36 months,23,1.7982799062
MPCD,TNF,Infection,Opportunistic infection,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,12 months,74,5.7857701329
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,24 months,82,6.4112587959
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,36 months,85,6.6458170446
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,AS cohort entry to exposure,65,5.082095387
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,12 months,39,3.0492572322
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,24 months,45,3.5183737295
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,36 months,47,3.6747458952
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,AS cohort entry to exposure,27,2.1110242377
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,24 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,36 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,12 months,9,0.7036747459
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,24 months,15,1.1727912432
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,36 months,17,1.3291634089
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,12 months,17,1.3291634089
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,24 months,19,1.4855355747
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,36 months,19,1.4855355747
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,AS cohort entry to exposure,11,0.8600469116
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,12 months,26,2.0328381548
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,24 months,37,2.8928850665
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,36 months,38,2.9710711493
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,12 months,55,4.3002345582
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,24 months,67,5.2384675528
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,36 months,72,5.6293979672
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,AS cohort entry to exposure,37,2.8928850665
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,12 months,83,6.4894448788
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,24 months,98,7.662236122
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,36 months,103,8.0531665364
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,AS cohort entry to exposure,70,5.4730258014
MPCD,TNF,Uveitis,Uveitis,1107,1279,12 months,108,8.4440969507
MPCD,TNF,Uveitis,Uveitis,1107,1279,24 months,121,9.4605160281
MPCD,TNF,Uveitis,Uveitis,1107,1279,36 months,126,9.8514464425
MPCD,TNF,Uveitis,Uveitis,1107,1279,AS cohort entry to exposure,90,7.036747459
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,12 months,16,0.782396088
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,36 months,23,1.1246943765
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,AS cohort entry to exposure,12,0.586797066
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,12 months,10,0.488997555
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,36 months,27,1.3202933985
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,AS cohort entry to exposure,6,0.293398533
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,12 months,85,4.1564792176
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,24 months,103,5.0366748166
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,36 months,115,5.6234718826
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,AS cohort entry to exposure,59,2.8850855746
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,12 months,18,0.880195599
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,24 months,28,1.369193154
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,36 months,34,1.662591687
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,AS cohort entry to exposure,13,0.6356968215
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,12 months,23,1.1246943765
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,24 months,30,1.466992665
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,36 months,32,1.564792176
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,AS cohort entry to exposure,13,0.6356968215
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,24 months,6,0.293398533
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,36 months,8,0.391198044
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,AS cohort entry to exposure,5,0.2444987775
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,12 months,99,4.8410757946
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,24 months,142,6.9437652812
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,36 months,151,7.3838630807
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,AS cohort entry to exposure,88,4.3031784841
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,12 months,31,1.5158924205
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,24 months,45,2.2004889976
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,36 months,49,2.3960880196
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,AS cohort entry to exposure,22,1.075794621
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,12 months,79,3.8630806846
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,24 months,88,4.3031784841
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,36 months,92,4.4987775061
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,AS cohort entry to exposure,69,3.3740831296
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,12 months,53,2.5916870416
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,24 months,63,3.0806845966
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,36 months,67,3.2762836186
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,AS cohort entry to exposure,28,1.369193154
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,24 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,36 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,24 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,36 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,24 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,36 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,12 months,15,0.7334963325
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,36 months,33,1.6136919315
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,AS cohort entry to exposure,18,0.880195599
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,24 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,12 months,4,0.195599022
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,24 months,9,0.4400977995
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,36 months,10,0.488997555
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,12 months,17,0.8312958435
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,36 months,26,1.271393643
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,AS cohort entry to exposure,7,0.3422982885
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,12 months,20,0.97799511
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,24 months,36,1.760391198
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,36 months,40,1.95599022
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,AS cohort entry to exposure,19,0.9290953545
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,12 months,73,3.5696821516
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,24 months,87,4.2542787286
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,36 months,100,4.8899755501
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,AS cohort entry to exposure,49,2.3960880196
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,12 months,131,6.4058679707
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,24 months,153,7.4816625917
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,36 months,157,7.6772616137
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,AS cohort entry to exposure,87,4.2542787286
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,12 months,139,6.7970660147
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,24 months,166,8.1173594132
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,36 months,175,8.5574572127
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,AS cohort entry to exposure,103,5.0366748166
Marketscan,NSAID,Cancer,Hematologic Cancer,3644,4893,12 months,21,0.4291845494
Marketscan,NSAID,Cancer,Hematologic Cancer,3644,4893,24 months,27,0.5518087063
Marketscan,NSAID,Cancer,Hematologic Cancer,3644,4893,36 months,29,0.5926834253
Marketscan,NSAID,Cancer,Hematologic Cancer,3644,4893,AS cohort entry to exposure,26,0.5313713468
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,3644,4893,12 months,43,0.8788064582
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,3644,4893,24 months,64,1.3079910076
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,3644,4893,36 months,72,1.4714898835
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,3644,4893,AS cohort entry to exposure,46,0.9401185367
Marketscan,NSAID,Cancer,Solid Cancer,3644,4893,12 months,177,3.6174126303
Marketscan,NSAID,Cancer,Solid Cancer,3644,4893,24 months,219,4.475781729
Marketscan,NSAID,Cancer,Solid Cancer,3644,4893,36 months,231,4.7210300429
Marketscan,NSAID,Cancer,Solid Cancer,3644,4893,AS cohort entry to exposure,152,3.106478643
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3644,4893,12 months,36,0.7357449418
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3644,4893,24 months,46,0.9401185367
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3644,4893,36 months,49,1.0014306152
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3644,4893,AS cohort entry to exposure,44,0.8992438177
Marketscan,NSAID,Cardiac disease,Conduction Block,3644,4893,12 months,47,0.9605558962
Marketscan,NSAID,Cardiac disease,Conduction Block,3644,4893,24 months,69,1.410177805
Marketscan,NSAID,Cardiac disease,Conduction Block,3644,4893,36 months,77,1.573676681
Marketscan,NSAID,Cardiac disease,Conduction Block,3644,4893,AS cohort entry to exposure,39,0.7970570202
Marketscan,NSAID,Cardiac disease,Myocardial infarction,3644,4893,12 months,19,0.3883098304
Marketscan,NSAID,Cardiac disease,Myocardial infarction,3644,4893,24 months,24,0.4904966278
Marketscan,NSAID,Cardiac disease,Myocardial infarction,3644,4893,36 months,32,0.6539955038
Marketscan,NSAID,Cardiac disease,Myocardial infarction,3644,4893,AS cohort entry to exposure,18,0.3678724709
Marketscan,NSAID,Infection,Hospitalized infection,3644,4893,12 months,238,4.8640915594
Marketscan,NSAID,Infection,Hospitalized infection,3644,4893,24 months,305,6.2333946454
Marketscan,NSAID,Infection,Hospitalized infection,3644,4893,36 months,335,6.8465154302
Marketscan,NSAID,Infection,Hospitalized infection,3644,4893,AS cohort entry to exposure,257,5.2524013897
Marketscan,NSAID,Infection,Opportunistic infection,3644,4893,12 months,41,0.8379317392
Marketscan,NSAID,Infection,Opportunistic infection,3644,4893,24 months,50,1.0218679747
Marketscan,NSAID,Infection,Opportunistic infection,3644,4893,36 months,58,1.1853668506
Marketscan,NSAID,Infection,Opportunistic infection,3644,4893,AS cohort entry to exposure,35,0.7153075823
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,3644,4893,12 months,89,1.8189249949
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,3644,4893,24 months,102,2.0846106683
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,3644,4893,36 months,108,2.2072348253
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,3644,4893,AS cohort entry to exposure,81,1.6554261189
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,3644,4893,12 months,57,1.1649294911
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,3644,4893,24 months,63,1.2875536481
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,3644,4893,36 months,68,1.3897404455
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,3644,4893,AS cohort entry to exposure,45,0.9196811772
Marketscan,NSAID,Kidney disease,Amyloidosis,3644,4893,12 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,Amyloidosis,3644,4893,24 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,Amyloidosis,3644,4893,36 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,Amyloidosis,3644,4893,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,3644,4893,12 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,IgA nephropathy,3644,4893,24 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,IgA nephropathy,3644,4893,36 months,2,0.040874719
Marketscan,NSAID,Kidney disease,IgA nephropathy,3644,4893,AS cohort entry to exposure,1,0.0204373595
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,3644,4893,12 months,1,0.0204373595
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,3644,4893,24 months,2,0.040874719
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,3644,4893,36 months,3,0.0613120785
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,3644,4893,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,3644,4893,12 months,2,0.040874719
Marketscan,NSAID,Lung disease,Interstitial lung disease,3644,4893,24 months,3,0.0613120785
Marketscan,NSAID,Lung disease,Interstitial lung disease,3644,4893,36 months,3,0.0613120785
Marketscan,NSAID,Lung disease,Interstitial lung disease,3644,4893,AS cohort entry to exposure,2,0.040874719
Marketscan,NSAID,Lung disease,Restrictive lung disease ,3644,4893,12 months,36,0.7357449418
Marketscan,NSAID,Lung disease,Restrictive lung disease ,3644,4893,24 months,44,0.8992438177
Marketscan,NSAID,Lung disease,Restrictive lung disease ,3644,4893,36 months,51,1.0423053342
Marketscan,NSAID,Lung disease,Restrictive lung disease ,3644,4893,AS cohort entry to exposure,38,0.7766196607
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,3644,4893,12 months,25,0.5109339873
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,3644,4893,24 months,35,0.7153075823
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,3644,4893,36 months,36,0.7357449418
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,3644,4893,AS cohort entry to exposure,16,0.3269977519
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,3644,4893,12 months,67,1.369303086
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,3644,4893,24 months,79,1.6145514
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,3644,4893,36 months,83,1.6963008379
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,3644,4893,AS cohort entry to exposure,62,1.2671162886
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3644,4893,12 months,95,1.9415491518
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3644,4893,24 months,119,2.4320457797
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3644,4893,36 months,134,2.7386061721
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3644,4893,AS cohort entry to exposure,86,1.7576129164
Marketscan,NSAID,PsO/PsA,Psoriasis,3644,4893,12 months,94,1.9211117924
Marketscan,NSAID,PsO/PsA,Psoriasis,3644,4893,24 months,119,2.4320457797
Marketscan,NSAID,PsO/PsA,Psoriasis,3644,4893,36 months,138,2.8203556101
Marketscan,NSAID,PsO/PsA,Psoriasis,3644,4893,AS cohort entry to exposure,81,1.6554261189
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,3644,4893,12 months,111,2.2685469037
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,3644,4893,24 months,133,2.7181688126
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,3644,4893,36 months,143,2.9225424075
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,3644,4893,AS cohort entry to exposure,104,2.1254853873
Marketscan,NSAID,Uveitis,Uveitis,3644,4893,12 months,329,6.7238912732
Marketscan,NSAID,Uveitis,Uveitis,3644,4893,24 months,387,7.9092581239
Marketscan,NSAID,Uveitis,Uveitis,3644,4893,36 months,410,8.3793173922
Marketscan,NSAID,Uveitis,Uveitis,3644,4893,AS cohort entry to exposure,269,5.4976497037
Marketscan,No exposure,Cancer,Hematologic Cancer,5696,5696,12 months,44,0.7724719101
Marketscan,No exposure,Cancer,Hematologic Cancer,5696,5696,24 months,49,0.860252809
Marketscan,No exposure,Cancer,Hematologic Cancer,5696,5696,36 months,55,0.9655898876
Marketscan,No exposure,Cancer,Hematologic Cancer,5696,5696,AS cohort entry to exposure,11,0.1931179775
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,5696,5696,12 months,42,0.7373595506
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,5696,5696,24 months,77,1.3518258427
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,5696,5696,36 months,94,1.6502808989
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,5696,5696,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cancer,Solid Cancer,5696,5696,12 months,247,4.3363764045
Marketscan,No exposure,Cancer,Solid Cancer,5696,5696,24 months,295,5.1790730337
Marketscan,No exposure,Cancer,Solid Cancer,5696,5696,36 months,328,5.7584269663
Marketscan,No exposure,Cancer,Solid Cancer,5696,5696,AS cohort entry to exposure,48,0.8426966292
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5696,5696,12 months,105,1.8433988764
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5696,5696,24 months,130,2.2823033708
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5696,5696,36 months,143,2.5105337079
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5696,5696,AS cohort entry to exposure,17,0.2984550562
Marketscan,No exposure,Cardiac disease,Conduction Block,5696,5696,12 months,108,1.8960674157
Marketscan,No exposure,Cardiac disease,Conduction Block,5696,5696,24 months,139,2.4403089888
Marketscan,No exposure,Cardiac disease,Conduction Block,5696,5696,36 months,154,2.7036516854
Marketscan,No exposure,Cardiac disease,Conduction Block,5696,5696,AS cohort entry to exposure,40,0.702247191
Marketscan,No exposure,Cardiac disease,Myocardial infarction,5696,5696,12 months,51,0.8953651685
Marketscan,No exposure,Cardiac disease,Myocardial infarction,5696,5696,24 months,62,1.0884831461
Marketscan,No exposure,Cardiac disease,Myocardial infarction,5696,5696,36 months,67,1.1762640449
Marketscan,No exposure,Cardiac disease,Myocardial infarction,5696,5696,AS cohort entry to exposure,21,0.3686797753
Marketscan,No exposure,Infection,Hospitalized infection,5696,5696,12 months,521,9.1467696629
Marketscan,No exposure,Infection,Hospitalized infection,5696,5696,24 months,624,10.95505618
Marketscan,No exposure,Infection,Hospitalized infection,5696,5696,36 months,673,11.815308989
Marketscan,No exposure,Infection,Hospitalized infection,5696,5696,AS cohort entry to exposure,224,3.9325842697
Marketscan,No exposure,Infection,Opportunistic infection,5696,5696,12 months,60,1.0533707865
Marketscan,No exposure,Infection,Opportunistic infection,5696,5696,24 months,81,1.4220505618
Marketscan,No exposure,Infection,Opportunistic infection,5696,5696,36 months,95,1.6678370787
Marketscan,No exposure,Infection,Opportunistic infection,5696,5696,AS cohort entry to exposure,3,0.0526685393
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,5696,5696,12 months,195,3.4234550562
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,5696,5696,24 months,229,4.0203651685
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,5696,5696,36 months,240,4.2134831461
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,5696,5696,AS cohort entry to exposure,78,1.3693820225
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5696,5696,12 months,166,2.9143258427
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5696,5696,24 months,186,3.2654494382
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5696,5696,36 months,194,3.4058988764
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5696,5696,AS cohort entry to exposure,41,0.7198033708
Marketscan,No exposure,Kidney disease,Amyloidosis,5696,5696,12 months,2,0.0351123596
Marketscan,No exposure,Kidney disease,Amyloidosis,5696,5696,24 months,2,0.0351123596
Marketscan,No exposure,Kidney disease,Amyloidosis,5696,5696,36 months,2,0.0351123596
Marketscan,No exposure,Kidney disease,Amyloidosis,5696,5696,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,5696,5696,12 months,9,0.158005618
Marketscan,No exposure,Kidney disease,IgA nephropathy,5696,5696,24 months,10,0.1755617978
Marketscan,No exposure,Kidney disease,IgA nephropathy,5696,5696,36 months,10,0.1755617978
Marketscan,No exposure,Kidney disease,IgA nephropathy,5696,5696,AS cohort entry to exposure,2,0.0351123596
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,5696,5696,12 months,1,0.0175561798
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,5696,5696,24 months,2,0.0351123596
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,5696,5696,36 months,2,0.0351123596
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,5696,5696,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,5696,5696,12 months,2,0.0351123596
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,5696,5696,24 months,2,0.0351123596
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,5696,5696,36 months,2,0.0351123596
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,5696,5696,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,5696,5696,12 months,9,0.158005618
Marketscan,No exposure,Lung disease,Interstitial lung disease,5696,5696,24 months,10,0.1755617978
Marketscan,No exposure,Lung disease,Interstitial lung disease,5696,5696,36 months,11,0.1931179775
Marketscan,No exposure,Lung disease,Interstitial lung disease,5696,5696,AS cohort entry to exposure,4,0.0702247191
Marketscan,No exposure,Lung disease,Restrictive lung disease ,5696,5696,12 months,105,1.8433988764
Marketscan,No exposure,Lung disease,Restrictive lung disease ,5696,5696,24 months,131,2.2998595506
Marketscan,No exposure,Lung disease,Restrictive lung disease ,5696,5696,36 months,150,2.6334269663
Marketscan,No exposure,Lung disease,Restrictive lung disease ,5696,5696,AS cohort entry to exposure,29,0.5091292135
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,5696,5696,12 months,4,0.0702247191
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,5696,5696,24 months,5,0.0877808989
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,5696,5696,36 months,5,0.0877808989
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,5696,5696,AS cohort entry to exposure,1,0.0175561798
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,5696,5696,12 months,20,0.3511235955
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,5696,5696,24 months,26,0.4564606742
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,5696,5696,36 months,28,0.4915730337
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,5696,5696,AS cohort entry to exposure,6,0.1053370787
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5696,5696,12 months,220,3.8623595506
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5696,5696,24 months,247,4.3363764045
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5696,5696,36 months,263,4.6172752809
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5696,5696,AS cohort entry to exposure,107,1.878511236
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5696,5696,12 months,124,2.1769662921
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5696,5696,24 months,169,2.966994382
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5696,5696,36 months,188,3.3005617978
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5696,5696,AS cohort entry to exposure,46,0.8075842697
Marketscan,No exposure,PsO/PsA,Psoriasis,5696,5696,12 months,125,2.1945224719
Marketscan,No exposure,PsO/PsA,Psoriasis,5696,5696,24 months,153,2.6860955056
Marketscan,No exposure,PsO/PsA,Psoriasis,5696,5696,36 months,173,3.0372191011
Marketscan,No exposure,PsO/PsA,Psoriasis,5696,5696,AS cohort entry to exposure,28,0.4915730337
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,5696,5696,12 months,147,2.580758427
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,5696,5696,24 months,179,3.1425561798
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,5696,5696,36 months,197,3.4585674157
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,5696,5696,AS cohort entry to exposure,43,0.7549157303
Marketscan,No exposure,Uveitis,Uveitis,5696,5696,12 months,445,7.8125
Marketscan,No exposure,Uveitis,Uveitis,5696,5696,24 months,514,9.0238764045
Marketscan,No exposure,Uveitis,Uveitis,5696,5696,36 months,541,9.4978932584
Marketscan,No exposure,Uveitis,Uveitis,5696,5696,AS cohort entry to exposure,95,1.6678370787
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,12 months,8,0.1384322547
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,24 months,16,0.2768645094
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,36 months,16,0.2768645094
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,12 months,30,0.5191209552
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,24 months,59,1.0209378785
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,36 months,72,1.2458902924
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,AS cohort entry to exposure,26,0.4499048278
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,12 months,103,1.7823152795
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,24 months,145,2.5090846167
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,36 months,157,2.7167329988
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,AS cohort entry to exposure,80,1.3843225472
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,12 months,47,0.8132894965
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,24 months,59,1.0209378785
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,36 months,70,1.2112822288
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,AS cohort entry to exposure,37,0.6402491781
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,12 months,41,0.7094653054
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,24 months,60,1.0382419104
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,36 months,71,1.2285862606
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,AS cohort entry to exposure,30,0.5191209552
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,12 months,11,0.1903443502
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,24 months,20,0.3460806368
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,36 months,21,0.3633846686
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,AS cohort entry to exposure,16,0.2768645094
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,12 months,204,3.5300224952
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,24 months,293,5.0700813289
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,36 months,332,5.7449385707
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,AS cohort entry to exposure,194,3.3569821768
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,12 months,68,1.1766741651
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,24 months,91,1.5746668974
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,36 months,101,1.7477072158
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,AS cohort entry to exposure,59,1.0209378785
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,12 months,320,5.5372901886
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,24 months,362,6.2640595259
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,36 months,373,6.4544038761
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,AS cohort entry to exposure,258,4.4644402146
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,12 months,209,3.6165426544
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,24 months,237,4.1010555459
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,36 months,254,4.3952240872
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,AS cohort entry to exposure,150,2.5956047759
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,12 months,2,0.0346080637
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,24 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,36 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,12 months,7,0.1211282229
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,24 months,9,0.1557362866
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,36 months,10,0.1730403184
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,12 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,36 months,6,0.103824191
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,12 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,36 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,12 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,36 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,AS cohort entry to exposure,4,0.0692161274
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,12 months,50,0.865201592
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,24 months,72,1.2458902924
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,36 months,82,1.4189306108
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,AS cohort entry to exposure,34,0.5883370825
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,36 months,2,0.0346080637
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,12 months,9,0.1557362866
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,24 months,14,0.2422564458
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,36 months,25,0.432600796
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,12 months,33,0.5710330507
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,24 months,46,0.7959854646
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,36 months,52,0.8998096556
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,AS cohort entry to exposure,24,0.4152967641
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,12 months,58,1.0036338467
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,24 months,98,1.6957951203
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,36 months,117,2.0245717252
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,AS cohort entry to exposure,50,0.865201592
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,12 months,252,4.3606160235
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,24 months,322,5.5718982523
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,36 months,361,6.246755494
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,AS cohort entry to exposure,179,3.0974216993
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,12 months,409,7.0773490223
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,24 months,476,8.2367191556
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,36 months,496,8.5827997924
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,AS cohort entry to exposure,334,5.7795466344
Marketscan,TNF,Uveitis,Uveitis,4797,5779,12 months,448,7.7522062641
Marketscan,TNF,Uveitis,Uveitis,4797,5779,24 months,517,8.946184461
Marketscan,TNF,Uveitis,Uveitis,4797,5779,36 months,553,9.5691296072
Marketscan,TNF,Uveitis,Uveitis,4797,5779,AS cohort entry to exposure,375,6.4890119398
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,12 months,85,1.6368187945
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,24 months,109,2.0989793953
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,36 months,118,2.2722896206
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,AS cohort entry to exposure,72,1.3864818024
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,12 months,67,1.2901983439
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,24 months,118,2.2722896206
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,36 months,159,3.0618139804
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,AS cohort entry to exposure,55,1.0591180435
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,12 months,399,7.6834199884
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,24 months,515,9.9171962257
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,36 months,583,11.226651261
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,AS cohort entry to exposure,340,6.5472751781
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,12 months,192,3.6972848065
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,24 months,288,5.5459272097
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,36 months,336,6.4702484113
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,AS cohort entry to exposure,161,3.1003273638
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,12 months,155,2.9847872136
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,24 months,228,4.3905257077
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,36 months,280,5.3918736761
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,AS cohort entry to exposure,130,2.503369921
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,12 months,47,0.9050645099
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,24 months,86,1.6560754862
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,36 months,125,2.4070864625
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,AS cohort entry to exposure,54,1.0398613518
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,12 months,717,13.807047949
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,24 months,1058,20.373579819
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,36 months,1292,24.879645677
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,AS cohort entry to exposure,825,15.886770653
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,12 months,144,2.7729636049
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,24 months,212,4.0824186405
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,36 months,251,4.8334296168
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,AS cohort entry to exposure,160,3.0810706721
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,12 months,342,6.5857885615
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,24 months,371,7.1442326208
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,36 months,386,7.4330829963
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,AS cohort entry to exposure,320,6.1621413441
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,12 months,187,3.601001348
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,24 months,222,4.2749855575
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,36 months,239,4.6023493164
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,AS cohort entry to exposure,199,3.8320816484
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,12 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,24 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,36 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,AS cohort entry to exposure,2,0.0385133834
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,12 months,10,0.192566917
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,24 months,16,0.3081070672
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,36 months,20,0.385133834
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,AS cohort entry to exposure,11,0.2118236087
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,12 months,12,0.2310803004
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,24 months,19,0.3658771423
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,36 months,20,0.385133834
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,AS cohort entry to exposure,8,0.1540535336
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,12 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,24 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,36 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,AS cohort entry to exposure,2,0.0385133834
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,12 months,56,1.0783747352
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,24 months,85,1.6368187945
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,36 months,101,1.9449258617
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,AS cohort entry to exposure,58,1.1168881186
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,12 months,176,3.3891777393
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,24 months,252,4.8526863085
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,36 months,311,5.9888311188
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,AS cohort entry to exposure,194,3.7357981899
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,12 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,24 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,36 months,3,0.0577700751
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,AS cohort entry to exposure,7,0.1347968419
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,12 months,21,0.4043905257
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,24 months,32,0.6162141344
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,36 months,34,0.6547275178
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,AS cohort entry to exposure,30,0.577700751
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,12 months,139,2.6766801464
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,24 months,223,4.2942422492
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,36 months,279,5.3726169844
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,AS cohort entry to exposure,184,3.5432312729
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,12 months,157,3.023300597
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,24 months,279,5.3726169844
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,36 months,358,6.8938956287
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,AS cohort entry to exposure,242,4.6601193915
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,12 months,251,4.8334296168
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,24 months,331,6.3739649528
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,36 months,386,7.4330829963
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,AS cohort entry to exposure,251,4.8334296168
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,12 months,422,8.1263238976
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,24 months,477,9.1854419411
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,36 months,514,9.897939534
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,AS cohort entry to exposure,394,7.5871365299
Medicare,DMARD,Uveitis,Uveitis,4231,5193,12 months,259,4.9874831504
Medicare,DMARD,Uveitis,Uveitis,4231,5193,24 months,319,6.1428846524
Medicare,DMARD,Uveitis,Uveitis,4231,5193,36 months,361,6.9516657038
Medicare,DMARD,Uveitis,Uveitis,4231,5193,AS cohort entry to exposure,292,5.6229539765
Medicare,NSAID,Cancer,Hematologic Cancer,8602,12847,12 months,195,1.5178640928
Medicare,NSAID,Cancer,Hematologic Cancer,8602,12847,24 months,226,1.7591655639
Medicare,NSAID,Cancer,Hematologic Cancer,8602,12847,36 months,255,1.9848991983
Medicare,NSAID,Cancer,Hematologic Cancer,8602,12847,AS cohort entry to exposure,211,1.6424067876
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,8602,12847,12 months,239,1.8603565035
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,8602,12847,24 months,375,2.9189694092
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,8602,12847,36 months,482,3.7518486806
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,8602,12847,AS cohort entry to exposure,236,1.8370047482
Medicare,NSAID,Cancer,Solid Cancer,8602,12847,12 months,1174,9.1383202304
Medicare,NSAID,Cancer,Solid Cancer,8602,12847,24 months,1430,11.131003347
Medicare,NSAID,Cancer,Solid Cancer,8602,12847,36 months,1598,12.438701642
Medicare,NSAID,Cancer,Solid Cancer,8602,12847,AS cohort entry to exposure,1225,9.5353000701
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8602,12847,12 months,489,3.8063361096
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8602,12847,24 months,642,4.9972756286
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8602,12847,36 months,755,5.8768584105
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8602,12847,AS cohort entry to exposure,591,4.6002957889
Medicare,NSAID,Cardiac disease,Conduction Block,8602,12847,12 months,422,3.2848135752
Medicare,NSAID,Cardiac disease,Conduction Block,8602,12847,24 months,630,4.9038686075
Medicare,NSAID,Cardiac disease,Conduction Block,8602,12847,36 months,768,5.97804935
Medicare,NSAID,Cardiac disease,Conduction Block,8602,12847,AS cohort entry to exposure,587,4.5691601152
Medicare,NSAID,Cardiac disease,Myocardial infarction,8602,12847,12 months,105,0.8173114346
Medicare,NSAID,Cardiac disease,Myocardial infarction,8602,12847,24 months,199,1.5489997665
Medicare,NSAID,Cardiac disease,Myocardial infarction,8602,12847,36 months,257,2.0004670351
Medicare,NSAID,Cardiac disease,Myocardial infarction,8602,12847,AS cohort entry to exposure,168,1.3076982953
Medicare,NSAID,Infection,Hospitalized infection,8602,12847,12 months,1711,13.318284424
Medicare,NSAID,Infection,Hospitalized infection,8602,12847,24 months,2421,18.844866506
Medicare,NSAID,Infection,Hospitalized infection,8602,12847,36 months,2868,22.324278042
Medicare,NSAID,Infection,Hospitalized infection,8602,12847,AS cohort entry to exposure,2468,19.210710672
Medicare,NSAID,Infection,Opportunistic infection,8602,12847,12 months,251,1.9537635246
Medicare,NSAID,Infection,Opportunistic infection,8602,12847,24 months,410,3.1914065541
Medicare,NSAID,Infection,Opportunistic infection,8602,12847,36 months,532,4.1410446019
Medicare,NSAID,Infection,Opportunistic infection,8602,12847,AS cohort entry to exposure,383,2.9812407566
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,8602,12847,12 months,404,3.1447030435
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,8602,12847,24 months,470,3.6584416595
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,8602,12847,36 months,499,3.8841752938
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,8602,12847,AS cohort entry to exposure,492,3.8296878649
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,8602,12847,12 months,215,1.6735424613
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,8602,12847,24 months,278,2.163929322
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,8602,12847,36 months,327,2.5453413248
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,8602,12847,AS cohort entry to exposure,324,2.5219895695
Medicare,NSAID,Kidney disease,Amyloidosis,8602,12847,12 months,7,0.054487429
Medicare,NSAID,Kidney disease,Amyloidosis,8602,12847,24 months,7,0.054487429
Medicare,NSAID,Kidney disease,Amyloidosis,8602,12847,36 months,9,0.0700552658
Medicare,NSAID,Kidney disease,Amyloidosis,8602,12847,AS cohort entry to exposure,10,0.0778391842
Medicare,NSAID,Kidney disease,IgA nephropathy,8602,12847,12 months,15,0.1167587764
Medicare,NSAID,Kidney disease,IgA nephropathy,8602,12847,24 months,20,0.1556783685
Medicare,NSAID,Kidney disease,IgA nephropathy,8602,12847,36 months,28,0.2179497159
Medicare,NSAID,Kidney disease,IgA nephropathy,8602,12847,AS cohort entry to exposure,42,0.3269245738
Medicare,NSAID,Kidney disease,Nephrotic syndrome,8602,12847,12 months,15,0.1167587764
Medicare,NSAID,Kidney disease,Nephrotic syndrome,8602,12847,24 months,19,0.1478944501
Medicare,NSAID,Kidney disease,Nephrotic syndrome,8602,12847,36 months,19,0.1478944501
Medicare,NSAID,Kidney disease,Nephrotic syndrome,8602,12847,AS cohort entry to exposure,17,0.1323266132
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,8602,12847,12 months,3,0.0233517553
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,8602,12847,24 months,3,0.0233517553
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,8602,12847,36 months,3,0.0233517553
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,8602,12847,AS cohort entry to exposure,3,0.0233517553
Medicare,NSAID,Lung disease,Interstitial lung disease,8602,12847,12 months,63,0.4903868607
Medicare,NSAID,Lung disease,Interstitial lung disease,8602,12847,24 months,88,0.6849848214
Medicare,NSAID,Lung disease,Interstitial lung disease,8602,12847,36 months,107,0.8328792714
Medicare,NSAID,Lung disease,Interstitial lung disease,8602,12847,AS cohort entry to exposure,100,0.7783918425
Medicare,NSAID,Lung disease,Restrictive lung disease ,8602,12847,12 months,334,2.5998287538
Medicare,NSAID,Lung disease,Restrictive lung disease ,8602,12847,24 months,525,4.0865571729
Medicare,NSAID,Lung disease,Restrictive lung disease ,8602,12847,36 months,645,5.0206273838
Medicare,NSAID,Lung disease,Restrictive lung disease ,8602,12847,AS cohort entry to exposure,506,3.9386627228
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,8602,12847,12 months,10,0.0778391842
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,8602,12847,24 months,15,0.1167587764
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,8602,12847,36 months,16,0.1245426948
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,8602,12847,AS cohort entry to exposure,20,0.1556783685
Medicare,NSAID,Neurological Disease,Spinal Cord compression,8602,12847,12 months,60,0.4670351055
Medicare,NSAID,Neurological Disease,Spinal Cord compression,8602,12847,24 months,82,0.6382813108
Medicare,NSAID,Neurological Disease,Spinal Cord compression,8602,12847,36 months,97,0.7550400872
Medicare,NSAID,Neurological Disease,Spinal Cord compression,8602,12847,AS cohort entry to exposure,95,0.7394722503
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,8602,12847,12 months,527,4.1021250097
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,8602,12847,24 months,743,5.7834513894
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,8602,12847,36 months,834,6.4917879661
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,8602,12847,AS cohort entry to exposure,771,6.0014011053
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8602,12847,12 months,565,4.3979139099
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8602,12847,24 months,836,6.5073558029
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8602,12847,36 months,1030,8.0174359773
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8602,12847,AS cohort entry to exposure,873,6.7953607846
Medicare,NSAID,PsO/PsA,Psoriasis,8602,12847,12 months,378,2.9423211645
Medicare,NSAID,PsO/PsA,Psoriasis,8602,12847,24 months,504,3.923094886
Medicare,NSAID,PsO/PsA,Psoriasis,8602,12847,36 months,579,4.5068887678
Medicare,NSAID,PsO/PsA,Psoriasis,8602,12847,AS cohort entry to exposure,513,3.9931501518
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,8602,12847,12 months,345,2.6854518565
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,8602,12847,24 months,414,3.2225422278
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,8602,12847,36 months,450,3.502763291
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,8602,12847,AS cohort entry to exposure,529,4.1176928466
Medicare,NSAID,Uveitis,Uveitis,8602,12847,12 months,482,3.7518486806
Medicare,NSAID,Uveitis,Uveitis,8602,12847,24 months,661,5.1451700786
Medicare,NSAID,Uveitis,Uveitis,8602,12847,36 months,760,5.9157780026
Medicare,NSAID,Uveitis,Uveitis,8602,12847,AS cohort entry to exposure,701,5.4565268156
Medicare,No exposure,Cancer,Hematologic Cancer,13275,13275,12 months,260,1.9585687382
Medicare,No exposure,Cancer,Hematologic Cancer,13275,13275,24 months,298,2.2448210923
Medicare,No exposure,Cancer,Hematologic Cancer,13275,13275,36 months,329,2.4783427495
Medicare,No exposure,Cancer,Hematologic Cancer,13275,13275,AS cohort entry to exposure,54,0.406779661
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,13275,13275,12 months,336,2.5310734463
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,13275,13275,24 months,510,3.8418079096
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,13275,13275,36 months,589,4.4369114878
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,13275,13275,AS cohort entry to exposure,7,0.0527306968
Medicare,No exposure,Cancer,Solid Cancer,13275,13275,12 months,1579,11.894538606
Medicare,No exposure,Cancer,Solid Cancer,13275,13275,24 months,1902,14.327683616
Medicare,No exposure,Cancer,Solid Cancer,13275,13275,36 months,2057,15.495291902
Medicare,No exposure,Cancer,Solid Cancer,13275,13275,AS cohort entry to exposure,194,1.461393597
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,13275,13275,12 months,805,6.0640301318
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,13275,13275,24 months,1021,7.6911487759
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,13275,13275,36 months,1125,8.4745762712
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,13275,13275,AS cohort entry to exposure,106,0.7984934087
Medicare,No exposure,Cardiac disease,Conduction Block,13275,13275,12 months,782,5.8907721281
Medicare,No exposure,Cardiac disease,Conduction Block,13275,13275,24 months,1022,7.6986817326
Medicare,No exposure,Cardiac disease,Conduction Block,13275,13275,36 months,1178,8.8738229755
Medicare,No exposure,Cardiac disease,Conduction Block,13275,13275,AS cohort entry to exposure,150,1.1299435028
Medicare,No exposure,Cardiac disease,Myocardial infarction,13275,13275,12 months,333,2.5084745763
Medicare,No exposure,Cardiac disease,Myocardial infarction,13275,13275,24 months,450,3.3898305085
Medicare,No exposure,Cardiac disease,Myocardial infarction,13275,13275,36 months,529,3.9849340866
Medicare,No exposure,Cardiac disease,Myocardial infarction,13275,13275,AS cohort entry to exposure,93,0.7005649718
Medicare,No exposure,Infection,Hospitalized infection,13275,13275,12 months,3257,24.534839925
Medicare,No exposure,Infection,Hospitalized infection,13275,13275,24 months,4032,30.372881356
Medicare,No exposure,Infection,Hospitalized infection,13275,13275,36 months,4437,33.423728814
Medicare,No exposure,Infection,Hospitalized infection,13275,13275,AS cohort entry to exposure,1031,7.7664783427
Medicare,No exposure,Infection,Opportunistic infection,13275,13275,12 months,341,2.5687382298
Medicare,No exposure,Infection,Opportunistic infection,13275,13275,24 months,480,3.615819209
Medicare,No exposure,Infection,Opportunistic infection,13275,13275,36 months,576,4.3389830508
Medicare,No exposure,Infection,Opportunistic infection,13275,13275,AS cohort entry to exposure,33,0.2485875706
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,13275,13275,12 months,619,4.6629001883
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,13275,13275,24 months,682,5.1374764595
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,13275,13275,36 months,717,5.4011299435
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,13275,13275,AS cohort entry to exposure,194,1.461393597
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,13275,13275,12 months,336,2.5310734463
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,13275,13275,24 months,414,3.1186440678
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,13275,13275,36 months,465,3.5028248588
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,13275,13275,AS cohort entry to exposure,61,0.4595103578
Medicare,No exposure,Kidney disease,Amyloidosis,13275,13275,12 months,12,0.0903954802
Medicare,No exposure,Kidney disease,Amyloidosis,13275,13275,24 months,13,0.0979284369
Medicare,No exposure,Kidney disease,Amyloidosis,13275,13275,36 months,15,0.1129943503
Medicare,No exposure,Kidney disease,Amyloidosis,13275,13275,AS cohort entry to exposure,1,0.0075329567
Medicare,No exposure,Kidney disease,IgA nephropathy,13275,13275,12 months,34,0.2561205273
Medicare,No exposure,Kidney disease,IgA nephropathy,13275,13275,24 months,51,0.384180791
Medicare,No exposure,Kidney disease,IgA nephropathy,13275,13275,36 months,62,0.4670433145
Medicare,No exposure,Kidney disease,IgA nephropathy,13275,13275,AS cohort entry to exposure,4,0.0301318267
Medicare,No exposure,Kidney disease,Nephrotic syndrome,13275,13275,12 months,28,0.2109227872
Medicare,No exposure,Kidney disease,Nephrotic syndrome,13275,13275,24 months,33,0.2485875706
Medicare,No exposure,Kidney disease,Nephrotic syndrome,13275,13275,36 months,37,0.2787193974
Medicare,No exposure,Kidney disease,Nephrotic syndrome,13275,13275,AS cohort entry to exposure,1,0.0075329567
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,13275,13275,12 months,2,0.0150659134
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,13275,13275,24 months,3,0.0225988701
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,13275,13275,36 months,3,0.0225988701
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,13275,13275,AS cohort entry to exposure,1,0.0075329567
Medicare,No exposure,Lung disease,Interstitial lung disease,13275,13275,12 months,99,0.7457627119
Medicare,No exposure,Lung disease,Interstitial lung disease,13275,13275,24 months,131,0.9868173258
Medicare,No exposure,Lung disease,Interstitial lung disease,13275,13275,36 months,147,1.1073446328
Medicare,No exposure,Lung disease,Interstitial lung disease,13275,13275,AS cohort entry to exposure,26,0.1958568738
Medicare,No exposure,Lung disease,Restrictive lung disease ,13275,13275,12 months,474,3.5706214689
Medicare,No exposure,Lung disease,Restrictive lung disease ,13275,13275,24 months,667,5.0244821092
Medicare,No exposure,Lung disease,Restrictive lung disease ,13275,13275,36 months,792,5.9661016949
Medicare,No exposure,Lung disease,Restrictive lung disease ,13275,13275,AS cohort entry to exposure,55,0.4143126177
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,13275,13275,12 months,35,0.263653484
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,13275,13275,24 months,42,0.3163841808
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,13275,13275,36 months,44,0.3314500942
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,13275,13275,AS cohort entry to exposure,9,0.0677966102
Medicare,No exposure,Neurological Disease,Spinal Cord compression,13275,13275,12 months,135,1.0169491525
Medicare,No exposure,Neurological Disease,Spinal Cord compression,13275,13275,24 months,157,1.1826741996
Medicare,No exposure,Neurological Disease,Spinal Cord compression,13275,13275,36 months,167,1.2580037665
Medicare,No exposure,Neurological Disease,Spinal Cord compression,13275,13275,AS cohort entry to exposure,20,0.1506591337
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,13275,13275,12 months,1318,9.9284369115
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,13275,13275,24 months,1524,11.480225989
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,13275,13275,36 months,1637,12.331450094
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,13275,13275,AS cohort entry to exposure,411,3.0960451977
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,13275,13275,12 months,650,4.8964218456
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,13275,13275,24 months,909,6.8474576271
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,13275,13275,36 months,1082,8.1506591337
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,13275,13275,AS cohort entry to exposure,132,0.9943502825
Medicare,No exposure,PsO/PsA,Psoriasis,13275,13275,12 months,441,3.3220338983
Medicare,No exposure,PsO/PsA,Psoriasis,13275,13275,24 months,572,4.3088512241
Medicare,No exposure,PsO/PsA,Psoriasis,13275,13275,36 months,628,4.7306967985
Medicare,No exposure,PsO/PsA,Psoriasis,13275,13275,AS cohort entry to exposure,68,0.5122410546
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,13275,13275,12 months,470,3.5404896422
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,13275,13275,24 months,540,4.0677966102
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,13275,13275,36 months,579,4.3615819209
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,13275,13275,AS cohort entry to exposure,111,0.8361581921
Medicare,No exposure,Uveitis,Uveitis,13275,13275,12 months,432,3.2542372881
Medicare,No exposure,Uveitis,Uveitis,13275,13275,24 months,550,4.143126177
Medicare,No exposure,Uveitis,Uveitis,13275,13275,36 months,620,4.670433145
Medicare,No exposure,Uveitis,Uveitis,13275,13275,AS cohort entry to exposure,57,0.4293785311
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,12 months,26,0.4385225164
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,24 months,44,0.7421150278
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,36 months,56,0.9445100354
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,AS cohort entry to exposure,28,0.4722550177
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,12 months,72,1.2143700455
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,24 months,116,1.9564850734
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,36 months,153,2.5805363468
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,AS cohort entry to exposure,69,1.1637712936
Medicare,TNF,Cancer,Solid Cancer,4866,5929,12 months,338,5.7007927138
Medicare,TNF,Cancer,Solid Cancer,4866,5929,24 months,422,7.1175577669
Medicare,TNF,Cancer,Solid Cancer,4866,5929,36 months,484,8.1632653061
Medicare,TNF,Cancer,Solid Cancer,4866,5929,AS cohort entry to exposure,291,4.9080789341
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,12 months,174,2.9347276101
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,24 months,239,4.0310339012
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,36 months,276,4.6550851746
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,AS cohort entry to exposure,172,2.9009951088
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,12 months,145,2.4456063417
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,24 months,210,3.5419126328
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,36 months,262,4.4189576657
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,AS cohort entry to exposure,131,2.2094788329
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,12 months,29,0.4891212683
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,24 months,62,1.0457075392
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,36 months,87,1.467363805
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,AS cohort entry to exposure,58,0.9782425367
Medicare,TNF,Infection,Hospitalized infection,4866,5929,12 months,542,9.1415078428
Medicare,TNF,Infection,Hospitalized infection,4866,5929,24 months,925,15.601281835
Medicare,TNF,Infection,Hospitalized infection,4866,5929,36 months,1132,19.092595716
Medicare,TNF,Infection,Hospitalized infection,4866,5929,AS cohort entry to exposure,673,11.350986676
Medicare,TNF,Infection,Opportunistic infection,4866,5929,12 months,161,2.7154663518
Medicare,TNF,Infection,Opportunistic infection,4866,5929,24 months,240,4.0479001518
Medicare,TNF,Infection,Opportunistic infection,4866,5929,36 months,287,4.8406139315
Medicare,TNF,Infection,Opportunistic infection,4866,5929,AS cohort entry to exposure,192,3.2383201214
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,12 months,497,8.3825265643
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,24 months,538,9.0740428403
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,36 months,554,9.3439028504
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,AS cohort entry to exposure,459,7.7416090403
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,12 months,229,3.8623713948
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,24 months,288,4.8574801822
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,36 months,314,5.2960026986
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,AS cohort entry to exposure,229,3.8623713948
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,12 months,6,0.1011975038
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,24 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,36 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,AS cohort entry to exposure,7,0.1180637544
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,12 months,7,0.1180637544
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,24 months,15,0.2529937595
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,36 months,22,0.3710575139
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,AS cohort entry to exposure,17,0.2867262608
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,12 months,12,0.2023950076
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,24 months,22,0.3710575139
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,36 months,25,0.4216562658
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,AS cohort entry to exposure,8,0.1349300051
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,12 months,26,0.4385225164
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,24 months,42,0.7083825266
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,36 months,55,0.9276437848
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,AS cohort entry to exposure,37,0.6240512734
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,12 months,145,2.4456063417
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,24 months,246,4.1490976556
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,36 months,295,4.9755439366
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,AS cohort entry to exposure,184,3.1033901164
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,12 months,8,0.1349300051
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,24 months,13,0.2192612582
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,36 months,14,0.2361275089
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,AS cohort entry to exposure,3,0.0505987519
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,12 months,15,0.2529937595
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,24 months,22,0.3710575139
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,36 months,31,0.5228537696
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,AS cohort entry to exposure,23,0.3879237645
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,12 months,109,1.8384213189
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,24 months,187,3.1539888683
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,36 months,242,4.0816326531
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,AS cohort entry to exposure,170,2.8672626075
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,12 months,172,2.9009951088
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,24 months,286,4.8237476809
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,36 months,382,6.4429077416
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,AS cohort entry to exposure,247,4.1659639062
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,12 months,416,7.0163602631
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,24 months,519,8.7535840783
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,36 months,568,9.5800303593
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,AS cohort entry to exposure,392,6.6115702479
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,12 months,624,10.524540395
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,24 months,706,11.907572947
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,36 months,755,12.734019228
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,AS cohort entry to exposure,619,10.440209142
Medicare,TNF,Uveitis,Uveitis,4866,5929,12 months,408,6.8814302581
Medicare,TNF,Uveitis,Uveitis,4866,5929,24 months,511,8.6186540732
Medicare,TNF,Uveitis,Uveitis,4866,5929,36 months,585,9.86675662
Medicare,TNF,Uveitis,Uveitis,4866,5929,AS cohort entry to exposure,447,7.5392140327
